Biosimilars Market Product [Recombinant Non-Glycosylated Proteins (Insulin ...

26-11-2013 Sacramento BeeComments (0)


The biosimilar products market is segmented into recombinant non-glycosylated proteins, recombinant glycosylated proteins, and recombinant peptides. The recombinant non-glycosylated proteins market is further segmented as insulin, granulocyte ...

Read more on Sacramento Bee

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top